FYI | Dec 18 2019
Download related file: Monthly-LIC-Report-16-December-2019
A Listed Investment Company (LIC) is a listed investment vehicle that offers investors access to a diversified portfolio of shares in other companies also listed on the stock market.
Note: For comprehensive comparative data tables for LICs and ETFs please see attached.
Hearts & Minds Raises More Capital
Hearts and Minds Investments Limited ((HM1)) announced a renounceable pro-rata entitlement offer at $2.50 per share to raise up to a maximum of $62.5m. Shareholders will be entitled to 1 new HM1 share for every 8 HM1 shares they currently own. The raising is being done at a 20% discount to the HM1 closing price prior to the announcement. The $2.50 offer price also represents an 18% discount to the most recent HM1 NTA (before tax on unrealised gains) prior to the announcement. We are generally not in favour of LMIs raising capital at a discount to NTA given the dilutive effect. However, we note that this is a pro rata offer to all existing shareholders with shareholders able to sell their entitlement if they do not wish to take up new shares. This means all existing shareholders are being treated equally. Still, HM1 has generally traded at small premiums or discounts to NTA since listing, so we are unsure as to why it chose to undertake a raising at such a large discount.
The proceeds of the offer will be allocated primarily to HM1's new Core Fund Manager, TDM Growth Partners. As with the other Core Fund Managers in the HM1 stable the funds allocated to TDM Growth Partners will be invested in the manager's top three highest conviction ideas. As a result of TDM Growth Partners joining the Core Fund Managers group, HM1 has also announced that it is slightly altering the asset allocations between its two groups of fund managers. The allocation to the Conference Fund Managers will drop from 40% to 35% and subsequently the allocation to the Core Fund Managers will increase to 65% from 60%.
The final results of the offer will be known on the 19th of the December 2019. The directors of HM1 have already announced that they will be taking up their entitlements under the offer in full.
HM1 has performed well since listing and over the 12 months to 30 November the portfolio delivered an investment performance of 30.1% before expenses and taxes, well above the benchmark return of 23.6%. Our rating for HM1 is Recommended Plus.
ASIC Investigates Regal Funds Management
Regal Funds Management, the investment manager for the Regal Investment Fund ((RF1)), announced a preliminary investigation that it is part of a preliminary investigation by ASIC by way of a search warrant, in relation to its trading in certain securities. Australian Federal Police executed a search warrant at the offices of Regal Funds Management on behalf of ASIC at the end of November. Trading in RF1's securities was halted ahead of the announcement, but recommenced after the announcement.
Regal Funds Management is working with the regulator and notes that the investigation is preliminary in nature but has not disclosed what the investigation specifically relates to. At this stage we await further information. Regal Funds Management continues to manage the assets of RF1 and it says the investigation does not impact its ability to provide fund management services to its clients.
At this stage we see no reason to change our Recommended Plus rating for RF1. The portfolio continues to be managed in accordance with the original mandate. However, news of the ASIC investigation does seem to have contributed somewhat to a fall in the security price of RF1 and to a widening of the discount to RF1's underlying NTA. We will continue to watch closely.
CD1 & CD2 Wind up Motions Defeated
In our last LMI Monthly Update we wrote about the proposal by Walsh & Company Investments Limited to wind up both Cordish Dixon Private Equity Fund 1 (( CD1)) and Cordish Dixon Private Equity Fund 2 ((CD2)). The proposal was to realise the assets in both funds and subsequently return those funds to shareholders through an orderly wind up.
However, at the respective shareholder meetings on the 26th of November, both sale proposals were roundly defeated with over 90% of shareholders voting against the sale proposals. Following the defeat of the proposals the funds will continue to operate in line with their investment strategies. With both funds in the harvest phase there will continue to be a gradual realisation of the underlying investments.
Barrack St Changes its Name and Announces Distribution Partnership
Following shareholder approval at its recent AGM, listed investment company Barrack St Investments has changed its name to ECP Emerging Growth Limited ((ECP)). It also announced that its manager, ECP Asset Management, has signed a distribution partnership with Copia Investment Partners which will provide exclusive distribution and marketing support for ECP. ECP remains a small LIC with a market cap of just $17.6m. At the end of October it was trading at a 27.3% discount to pre-tax NTA. The discount has narrowed since the announcement of the partnership with Copia but remains significant. Whether the relationship leads to a substantial and sustained narrowing of the discount over time remains to be seen.
Spotlight on Global Masters Fund Limited
Global Masters Fund Limited ((GFL)), commenced trading on the ASX on 27 November 2006. Its primary objective is to participate in long term capital growth by investing in quality global assets. GFL has one major investment with its primary portfolio holding being in the New York Stock Exchange listed investment company, Berkshire Hathaway Inc. Notwithstanding the strong past performance of its investment in Berkshire Hathaway, GFL believes this company has the potential to continue to enjoy positive returns into the future.
The primary source of value creation for GFL shareholders is the capital appreciation of their shares, since Berkshire Hathaway does not pay a dividend and any excess cash received by the Company after paying expenses is reinvested.
The GFL Board takes the view that international investments provide currency diversification to investors and so any underlying foreign currency exposure is not hedged. The two major underlying currency exposures in GFL are USD and GBP.
GFL's holding in Berkshire Hathaway represents 64.27% of the portfolio, invested in both Class A and Class B shares. It also has a 3.12% weighting to Athelney Trust Plc, an investment company listed in the UK that has a focus on UK listed small cap investments. GFL also invests directly in UK shares, predominantly mid and small-caps. This currently constitutes 18.50% of its portfolio. A more recent addition has seen GFL invest 5.14% in the BIP BCI Worldwide Flexible Fund Class B listed on the Johannesburg Stock Exchange. To help generate cash to pay costs, GFL also has a 8.25% weighting to Australian LIC, Flagship Investments Limited ((FSI)).
As at 31 October 2019 GFL was trading at a 25.1% discount to its pre-tax NTA, well above its three year average discount of 8.3%. The discount is well above the IIR LMI International Specialist shares peer group which trades currently at an average discount of 12.2%. The current discount also represents one of largest discounts to NTA across the entire IIR LMI universe. In our view the current discount provides an attractive entry point for investors who are seeking exposure to some high quality underlying investments. Potential investors should be aware that there is a large difference between the pre-tax and post-tax NTA for GFL given some significant unrealised gains on its portfolio. However, even after the provision for tax on these unrealised gains its shares are still at a sizable discount. GFL currently holds a Recommended Plus rating from IIR.
GFL is not a yield stock as its largest investment does not pay dividends. It is suited more to investors seeking long-term capital growth.
This will be our last LMI Monthly Update for 2019. We wish all our readers a safe and happy festive season and continued health, wealth and happiness in 2020.
Independent Investment Research, "IIR", is an independent investment research house based in Australia and the United States. IIR specialises in the analysis of high quality commissioned research for Brokers, Family Offices and Fund Managers. IIR distributes its research in Asia, United States and the Americas. IIR does not participate in any corporate or capital raising activity and therefore it does not have any inherent bias that may result from research that is linked to any corporate/ capital raising activity.
IIR was established in 2004 under Aegis Equities Research Group of companies to provide investment research to a select group of retail and wholesale clients. Since March 2010, IIR (the Aegis Equities business was sold to Morningstar) has operated independently from Aegis by former Aegis senior executives/shareholders to provide clients with unparalleled research that covers listed and unlisted managed investments, listed companies, structured products, and IPOs. IIR takes great pride in the quality and independence of our analysis, underpinned by high caliber staff and a transparent, proven and rigorous research methodology.
INDEPENDENCE OF RESEARCH ANALYSTS
Research analysts are not directly supervised by personnel from other areas of the Firm whose interests or functions may conflict with those of the research analysts. The evaluation and appraisal of research analysts for purposes of career advancement, remuneration and promotion is structured so that non-research personnel do not exert inappropriate influence over analysts.
Supervision and reporting lines: Analysts who publish research reports are supervised by, and report to, Research Management. Research analysts do not report to, and are not supervised by, any sales personnel nor do they have dealings with Sales personnel
Evaluation and remuneration: The remuneration of research analysts is determined on the basis of a number of factors, including quality, accuracy and value of research, productivity, experience, individual reputation, and evaluations by investor clients.
INDEPENDENCE – ACTIVITIES OF ANALYSTS
IIR restricts research analysts from performing roles that could prejudice, or appear to prejudice, the independence of their research.
Pitches: Research analysts are not permitted to participate in sales pitches for corporate mandates on behalf of a Broker and are not permitted to prepare or review materials for those pitches. Pitch materials by investor clients may not contain the promise of research coverage by IIR.
No promotion of issuers' transactions: Research analysts may not be involved in promotional or marketing activities of an issuer of a relevant investment that would reasonably be construed as representing the issuer. For this reason, analysts are not permitted to attend "road show" presentations by issuers that are corporate clients of the Firm relating to offerings of securities or any other investment banking transaction from that our clients may undertake from time to time. Analysts may, however, observe road shows remotely, without asking questions, by video link or telephone in order to help ensure that they have access to the same information as their investor clients.
Widely-attended conferences: Analysts are permitted to attend and speak at widely-attended conferences at which our firm has been invited to present our views. These widely-attended conferences may include investor presentations by corporate clients of the Firm.
Other permitted activities: Analysts may be consulted by Firm sales personnel on matters such as market and industry trends, conditions and developments and the structuring, pricing and expected market reception of securities offerings or other market operations. Analysts may also carry out preliminary due diligence and vetting of issuers that may be prospective research clients of ours.
INDUCEMENTS AND INAPPROPRIATE INFLUENCES
IIR prohibits research analysts from soliciting or receiving any inducement in respect of their publication of research and restricts certain communications between research analysts and personnel from other business areas within the Firm including management, which might be perceived to result in inappropriate influence on analysts' views.
Remuneration and other benefits: IIR procedures prohibit analysts from accepting any remuneration or other benefit from an issuer or any other party in respect of the publication of research and from offering or accepting any inducement (including the selective disclosure by an issuer of material information not generally available) for the publication of favourable research. These restrictions do not preclude the acceptance of reasonable hospitality in accordance with the Firm's general policies on entertainment, gifts and corporate hospitality.
This publication has been prepared by Independent Investment Research (Aust) Pty Limited trading as Independent Investment Research ("IIR") (ABN 11 152 172 079), an corporate authorised representative of Australian Financial Services Licensee (AFSL no. 410381. IIR has been commissioned to prepare this independent research report (the "Report") and will receive fees for its preparation. Each company specified in the Report (the "Participants") has provided IIR with information about its current activities. While the information contained in this publication has been prepared with all reasonable care from sources that IIR believes are reliable, no responsibility or liability is accepted by IIR for any errors, omissions or misstatements however caused. In the event that updated or additional information is issued by the "Participants", subsequent to this publication, IIR is under no obligation to provide further research unless commissioned to do so. Any opinions, forecasts or recommendations reflects the judgment and assumptions of IIR as at the date of publication and may change without notice. IIR and each Participant in the Report, their officers, agents and employees exclude all liability whatsoever, in negligence or otherwise, for any loss or damage relating to this document to the full extent permitted by law. This publication is not and should not be construed as, an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. Any opinion contained in the Report is unsolicited general information only. Neither IIR nor the Participants are aware that any recipient intends to rely on this Report or of the manner in which a recipient intends to use it. In preparing our information, it is not possible to take into consideration the investment objectives, financial situation or particular needs of any individual recipient. Investors should obtain individual financial advice from their investment advisor to determine whether opinions or recommendations (if any) contained in this publication are appropriate to their investment objectives, financial situation or particular needs before acting on such opinions or recommendations. This report is intended for the residents of Australia. It is not intended for any person(s) who is resident of any other country. This document does not constitute an offer of services in jurisdictions where IIR or its affiliates do not have the necessary licenses. IIR and/or the Participant, their officers, employees or its related bodies corporate may, from time to time hold positions in any securities included in this Report and may buy or sell such securities or engage in other transactions involving such securities. IIR and the Participant, their directors and associates declare that from time to time they may hold interests in and/or earn brokerage, fees or other benefits from the securities mentioned in this publication.
IIR, its officers, employees and its related bodies corporate have not and will not receive, whether directly or indirectly, any commission, fee, benefit or advantage, whether pecuniary or otherwise in connection with making any statements and/or recommendation (if any), contained in this Report. IIR discloses that from time to time it or its officers, employees and related bodies corporate may have an interest in the securities, directly or indirectly, which are the subject of these statements and/or recommendations (if any) and may buy or sell securities in the companies mentioned in this publication; may affect transactions which may not be consistent with the statements and/or recommendations (if any) in this publication; may have directorships in the companies mentioned in this publication; and/or may perform paid services for the companies that are the subject of such statements and/or recommendations (if any). However, under no circumstances has IIR been influenced, either directly or indirectly, in making any statements and/or recommendations (if any) contained in this Report. The information contained in this publication must be read in conjunction with the Legal Notice that can be located at http://www.independentresearch.com.au/Public/Disclaimer.aspx.
Content included in this article is not by association the view of FNArena (see our disclaimer).
Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" – Warning this story contains unashamedly positive feedback on the service provided.
FNArena is proud about its track record and past achievements: Ten Years On